Investigator-Initiated Research (IIR) supports independent investigators with funding, study drug, or data and samples for research addressing unmet patient needs or important scientific questions.
Investigator Initiated Studies (IIS) supports scientists and clinical researchers pursuing independent clinical, observational, and outcomes research to explore questions or develop new treatment concepts.
Investigator-initiated Research (IIR) and Collaborative Research Grants support external investigators’ studies relevant to Neurocrine’s clinical programs to advance scientific knowledge and improve patient care.
Investigator Initiated Studies (IIS) Program supports independent investigators and institutions studying Eisai products and compounds to address medical or scientific questions in neurology and oncology.
Bayer's Investigator-Institution Initiated Research grant funds independent research projects advancing science in Bayer's key therapeutic areas.